Literature DB >> 20164248

Humoral immune responses in patients with Lyme neuroborreliosis.

Tjasa Cerar1, Katarina Ogrinc, Franc Strle, Eva Ruzić-Sabljić.   

Abstract

The aim of this study was to analyze and compare the humoral immune responses in serum and cerebrospinal fluid (CSF) for 34 adult patients with clinically evident Lyme neuroborreliosis, 27 patients with clinically suspected Lyme neuroborreliosis, and 32 patients with tick-borne encephalitis. Additionally, we wanted to compare the findings of two methods for the detection of intrathecally synthesized borrelial antibodies: the IDEIA Lyme neuroborreliosis test using flagellar antigen and an approach based on the Liaison indirect chemiluminescence immunoassay using the OspC and VlsE antigens. Borrelial IgM and IgG antibodies were detected by at least one of these methods in the sera of 22/34 (64.7%) and 28/34 (82.4%) patients with clinically evident Lyme neuroborreliosis, respectively, and in the cerebrospinal fluid of 22/34 (64.7%) and 20/34 (58.8%) of these patients, respectively. Intrathecal synthesis of borrelial IgM and/or IgG was found in 19/34 (55.9%) patients: IgM in 17/34 (50%) patients and IgG in 15/34 (44.1%) patients. The relatively low proportion of intrathecal synthesis of borrelial antibodies and the high ratio of IgM positivity could be explained by the short duration of neurological disease as evidenced by reported symptoms (median, 10 days). Assessment of the humoral immune response in the sera and CSF of patients with early Lyme neuroborreliosis confirmed previous findings on the relationship between the duration of illness and the proportion of patients with detectable responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164248      PMCID: PMC2849339          DOI: 10.1128/CVI.00341-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  23 in total

Review 1.  Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.

Authors:  H Reiber; J B Peter
Journal:  J Neurol Sci       Date:  2001-03-01       Impact factor: 3.181

2.  Barrier concepts and CSF analysis.

Authors:  K Felgenhauer
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

3.  The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid.

Authors:  Pieter Vermeersch; Sara Resseler; Elke Nackers; Katrien Lagrou
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-18       Impact factor: 2.803

4.  Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis.

Authors:  Ulrike Schulte-Spechtel; Gisela Lehnert; Gaby Liegl; Volker Fingerle; Christiane Heimerl; Barbara J B Johnson; Bettina Wilske
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Double infection with tick borne encephalitis virus and Borrelia burgdorferi sensu lato.

Authors:  Joze Cimperman; Vera Maraspin; Stanka Lotric-Furlan; Eva Ruzić-Sabljić; Tatjana Avsic-Zupanc; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2002-07-31       Impact factor: 1.704

6.  Cross-reactive antigenic domains of the flagellin protein of Borrelia burgdorferi.

Authors:  B J Luft; J J Dunn; R J Dattwyler; G Gorgone; P D Gorevic; W H Schubach
Journal:  Res Microbiol       Date:  1993-05       Impact factor: 3.992

Review 7.  Lyme borreliosis.

Authors:  Gerold Stanek; Franc Strle
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

8.  Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain.

Authors:  H Reiber; P Lange
Journal:  Clin Chem       Date:  1991-07       Impact factor: 8.327

9.  Western blotting in the serodiagnosis of Lyme disease.

Authors:  F Dressler; J A Whalen; B N Reinhardt; A C Steere
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

Authors:  S Hammers-Berggren; K Hansen; A M Lebech; M Karlsson
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

View more
  12 in total

1.  Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis.

Authors:  Gerold Stanek; Lara Lusa; Katarina Ogrinc; Mateusz Markowicz; Franc Strle
Journal:  Med Microbiol Immunol       Date:  2013-12-23       Impact factor: 3.402

Review 2.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  Comparison of the Euroimmun Borrelia 'antibody index' with Virotech immunoblot-based detection of intrathecal Borrelia antibody production for the diagnosis of Lyme neuroborreliosis.

Authors:  Erika De Bont; Katrien Lagrou; Melissa Depypere
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-09-13       Impact factor: 3.267

4.  Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.

Authors:  T Cerar; K Ogrinc; S Lotric-Furlan; J Kobal; S Levicnik-Stezinar; F Strle; E Ruzić-Sabljic
Journal:  Clin Vaccine Immunol       Date:  2013-08-14

5.  Acute facial nerve palsy in children in a Lyme disease-endemic area in the Netherlands.

Authors:  R A Bruinsma; C A Smulders; Y M Vermeeren; B van Kooten; E A Cats; B van Hees; M Boele van Hensbroek; J W Hovius; T P Zomer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-05-11       Impact factor: 3.267

6.  Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.

Authors:  Tamara van Gorkom; Willem Voet; Gijs H J van Arkel; Michiel Heron; B J A Hoeve-Bakker; Daan W Notermans; Steven F T Thijsen; Kristin Kremer
Journal:  Microbiol Spectr       Date:  2022-06-21

7.  Can ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis?

Authors:  Marika Nordberg; Pia Forsberg; Dag Nyman; Barbro H Skogman; Clara Nyberg; Jan Ernerudh; Ingvar Eliasson; Christina Ekerfelt
Journal:  Cells       Date:  2012-06-08       Impact factor: 6.600

Review 8.  The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Authors:  M M G Leeflang; C W Ang; J Berkhout; H A Bijlmer; W Van Bortel; A H Brandenburg; N D Van Burgel; A P Van Dam; R B Dessau; V Fingerle; J W R Hovius; B Jaulhac; B Meijer; W Van Pelt; J F P Schellekens; R Spijker; F F Stelma; G Stanek; F Verduyn-Lunel; H Zeller; H Sprong
Journal:  BMC Infect Dis       Date:  2016-03-25       Impact factor: 3.090

9.  An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.

Authors:  T van Gorkom; S U C Sankatsing; W Voet; D M Ismail; R H Muilwijk; M Salomons; B J M Vlaminckx; A W J Bossink; D W Notermans; J J M Bouwman; K Kremer; S F T Thijsen
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

10.  Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases.

Authors:  Kunal Garg; Leena Meriläinen; Ole Franz; Heidi Pirttinen; Marco Quevedo-Diaz; Stephen Croucher; Leona Gilbert
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.